Personalized RT
We utilize genetic testing, biomarker analysis, and patient-specific data to customize radiation treatment plans.
Decipher
The Decipher prostate genomic test helps with radiation treatment decisions by predicting the likelihood of cancer returning or spreading after surgery. If the test shows a higher risk, doctors may recommend more aggressive treatments like adding radiation therapy to reduce the chance of recurrence.
DCISion RT
DCISion RT is a genomic test used for patients with ductal carcinoma in situ (DCIS) to guide radiation therapy decisions. It analyzes the biology of the DCIS to predict the risk of recurrence after surgery. This helps doctors and patients decide whether radiation therapy is needed, allowing for more personalized treatment plans.
